The 2020 annual report of DataDerm: The database of the American Academy of Dermatology - 10/03/21
, Robert A. Swerlick, MD b, Barbara Mathes, MD c, George J. Hruza, MD, MBA d, Jack Resneck, MD e, Hon S. Pak, MD f, Toni Kaye, BS, MPH g, Arik Aninos, BS, MSc g, Bianca Agregado, BA g, Matthew Fitzgerald, MPH, DrPH g, Jeffrey P. Jacobs, MD g, hAbstract |
The American Academy of Dermatology launched DataDerm in 2016 as the clinical data registry platform of the American Academy of Dermatology. DataDerm is approved by the Centers for Medicare & Medicaid Services as a Qualified Clinical Data Registry for the Merit-Based Incentive Payment System. The ultimate purpose of DataDerm is to provide dermatologists with a registry and database that will serve as a vehicle to advance the specialty in the domains of science, discovery, education, quality assessment, quality improvement, advocacy, and practice management.
DataDerm is currently the largest clinical registry and database of patients receiving dermatologic care in the world. As of December 31, 2019, DataDerm contained data from 10,618,879 unique patients and 32,309,389 unique patient visits. Depending on the reporting period, 800 to 900 practices (representing 2400-2600 clinicians) actively participate in DataDerm by submitting data.
This article provides the first of a planned series of annual updates of the status of DataDerm. The purpose of this article is to present the rationale for the creation, maintenance, history, and current status of DataDerm, as well as the future plans for DataDerm.
Le texte complet de cet article est disponible en PDF.Key words : database, dermatology, outcomes, quality, registry, safety
Abbreviations used : AAD, AAD, CMS, EHR, IDEOM, MIPS, PQRS, PRO, QCDR, QPP, RUC
Plan
| Drs Van Beek and Swerlick are cofirst authors. |
|
| Funding sources: None. |
|
| Accepted for publication November 27, 2020. |
|
| IRB approval status: Not applicable. |
Vol 84 - N° 4
P. 1037-1041 - avril 2021 Retour au numéro
Article précédent
- Mohs micrographic surgery for male genital tumors: Local recurrence rates and patient-reported outcomes
- Tess M. Lukowiak, Allison M. Perz, Leora Aizman, Robert Caleb Kovell, Stephen Kovach, John P. Fischer, Aimee Krausz, Cerrene Giordano, H. William Higgins, Thuzar M. Shin, Joseph F. Sobanko, Jeremy R. Etzkorn, Stacy McMurray, Raju Chelluri, Thomas Guzzo, Christopher J. Miller
- Dietary supplements in dermatology: A review of the evidence for zinc, biotin, vitamin D, nicotinamide, and Polypodium
- Katherine G. Thompson, Noori Kim
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?